Sensus Healthcare Announces Medical Director and Medical Advisory Board

Press Release

February 14, 2011

Boca Raton, FL

Sensus Healthcare has announced Dr. Armand B. Cognetta as its Medical Director and Chair of the Medical Advisory Board. Dr. Cognetta will provide clinical guidance and patient advocacy in the ongoing development of the Company’s leading Superficial Radiotherapy product platform, the SRT-100™, and also lead the Company’s multi-disciplinary Medical Advisory Board in providing Sensus with clinical, ethical, and scientific counseling on the development of its future products and services. “I am pleased to accept the medical directorship with Sensus Healthcare and lead its Medical Advisory Board. I am a firm believer in providing patients with all available treatment options, thus delivering the most optimal therapy for every patient. It is the duty of a physician to discuss and design a treatment plan with their patient, which takes into account not only the disease but the physical health and well-being of the patient. In the case of basal cell and squamous cell carcinoma as patients age and have one or more medical problems or are frail, nonsurgical alternatives need to be explored. Photon RT is a therapeutic alternative to surgery or electron beam in elderly patients with certain tumor subtypes and locations. This is a time honored non-surgical modality which can be highly efficacious in select skin cancers yet still be extremely cost effective when compare to surgery or electron beam therapy. I am thrilled by what the future holds in new discoveries and possibilities for our clinical community and the patients.” –Dr. Armand Cognetta – Medical Director, Sensus Healthcare “Moufassah’s Quote Goes Here…” –Joseph C. Sardano, President & CEO Sensus Healthcare   About Sensus Healthcare: Sensus Healthcare specializes in making proven non-melanoma skin cancer solutions more accessible to patients. Our dedicated superficial radiation therapy (SRT) systems are designed specifically to provide an alternative to surgical procedures for basal cell and squamous cell carcinomas. Our mobile, compact SRT-100™ systems are used widely by oncologists and dermatologists to bring non-melanoma skin cancer treatment to more patients in more settings. We also offer a professional skin care line, Sensus Skin Solutions™, through our physician SRT-100™ users for their patients.   Contact: Vicky Perez Public Relations 561-922-5808 Ext 108

The Benefits of SRT

Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:

  1. 95%+ cure rates that rival surgery
  2. No anesthesia, cutting, bleeding, stitching or pain
  3. No downtime or lifestyle restrictions
  4. Super cosmesis, no unsightly scarring
  5. No need for post-treatment reconstructive surgeries